HighTower Advisors
INBX icon

HighTower Advisors’s Inhibrx INBX Stock Holding History

HighTower Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.5M Buy
870,551
+351
+0% +$35.2K 0.08% 250
2026
Q1 		$58.5M Sell
870,200
-307
-0% -$22.8K 0.06% 318
2025
Q4 		$68.8M Sell
870,507
-1,252
-0.1% -$85.3K 0.08% 260
2025
Q3 		$29.4M Hold
871,759
– – 0.03% 489
2025
Q2 		$12.4M Buy
871,759
+5
+0% +$65 0.02% 719
2025
Q1 		$12.2M Buy
871,754
+90,002
+12% +$1.22M 0.02% 693
2024
Q4 		$12M Buy
781,752
+659,252
+538% +$10M 0.02% 678
2024
Q3 		$1.92M Buy
122,500
+15,000
+14% +$211K ﹤0.01% 1545
2024
Q2 		$1.52M Buy
+107,500
New +$1.68M ﹤0.01% 1601

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HighTower Advisors's INBX Position: Q2 2026 in Review

HighTower Advisors increased its Inhibrx (INBX) stake by 0.04% in Q2 2026, buying an estimated $35.2K and bringing the position to 870,551 shares worth $82.5M. The position accounts for 0.08% of the portfolio, ranked #250.

HighTower Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • HighTower Advisors held 870,551 shares of Inhibrx worth $82.5M as of Q2 2026.
  • HighTower Advisors bought 351 Inhibrx shares in Q2 2026, an estimated $35.2K.
  • Inhibrx made up 0.08% of HighTower Advisors's portfolio in Q2 2026, its #250 holding.
  • HighTower Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.